Vol. 18 No. 3 (2024): Revista Reumatología al Día
Reportes de Casos Clínicos

Oligoarthritis, a form of presentation of ankylosing spondylitis

PDF (Español (España))
  • Santiago Andrés Guzmán-García,
  • José Elías Samaniego Burneo,
  • Karen Stefany Armijos Pardo
Santiago Andrés Guzmán-García
Hospital Clínica San Agustín, Loja-Ecuador
José Elías Samaniego Burneo
Universidad Técnica Particular de Loja, Loja-Ecuador
Karen Stefany Armijos Pardo
Universidad Técnica Particular de Loja, Loja-Ecuador
DOI: https://doi.org/10.62484/rad.v18i3.9260

Published 2024-12-24

Keywords

  • Spondyloarthritis axial,
  • ankylosing spondylitis,
  • secukinumab,
  • rheumatoid arthritis

How to Cite

Guzmán-García, S. A., Samaniego Burneo, J. E., & Armijos Pardo, K. S. (2024). Oligoarthritis, a form of presentation of ankylosing spondylitis. Reumatología Al Día, 18(3), 6. https://doi.org/10.62484/rad.v18i3.9260

Copyright (c) 2024 Reumatología al Día

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Abstract

Ankylosing spondylitis is a chronic inflammatory disease that primarily affects the axial skeleton and sacroiliac joints. However, it can also involve peripheral joints, which in some cases is a challenge in the differential diagnosis with other rheumatic diseases. This case presents a young man with a clinical presentation of peripheral oligoarthritis and lower back pain who was initially diagnosed with rheumatoid arthritis. Although the coexistence of both diseases is uncommon, it is essential to consider them in the differential diagnosis. Imaging studies and laboratory tests are crucial pillars in the diagnosis of this condition. Treatment with secukinumab demonstrated significant improvement in the patient's clinical status. These new biological therapies have proven to enhance quality of life and prognosis, emphasizing the need for a therapeutic approach tailored to each case.

PDF (Español (España))

Metrics

Metrics Loading ...

References

  1. Ebrahimiadib N, Berijani S, Ghahari M, Pahlaviani FG. Ankylosing Spondylitis. J Ophthalmic Vis Res. 29 de julio de 2021;16(3):462-9.
  2. Spondyloarthropathies. Rheum Dis Clin North Am. febrero de 1992;18(1):1-276.
  3. Sanhueza Z. A, Prieto R. JC, Weisz C. J, Leiter Herrán F, Soto F. S, Chiang O. F, et al. Espondiloartritis anquilosante: revisión de hallazgos imagenológicos en la columna. Rev Chil Radiol. 1 de octubre de 2016;22(4):171-83.
  4. Dean LE, Jones GT, MacDonald AG, Downham C, Sturrock RD, Macfarlane GJ. Global prevalence of ankylosing spondylitis. Rheumatol Oxf Engl. abril de 2014;53(4):650-7.
  5. Barczyńska TA, Węgierska M, Żuchowski P, Dura M, Zalewska J, Waszczak M, et al. Coexistence of rheumatoid arthritis and ankylosing spondylitis. Reumatologia. 2015;53(5):279-85.
  6. Agrawal P, Tote S, Sapkale B. Diagnosis and Treatment of Ankylosing Spondylitis. Cureus [Internet]. 19 de enero de 2024 [citado 15 de julio de 2024];16(1). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10874590/
  7. Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, et al. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis. Arthritis Care Res. octubre de 2019;71(10):1285-99.
  8. Toussirot E, Acquaviva PC. Coexisting rheumatoid arthritis and ankylosing spondylitis discussion of 3 cases with review of the literature. Clin Rheumatol. septiembre de 1995;14(5):554-60.
  9. Zhang Y, Feng B, Dong J, Zhong Y, Wang L, Zhao L. Rheumatoid arthritis coexisting with ankylosing spondylitis. Medicine (Baltimore). 2 de abril de 2021;100(13):e25051.
  10. Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A, Landewé R, Dougados M, Mielants H, et al. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum. 15 de abril de 2004;51(2):154-9.
  11. Gouveia EB, Elmann D, Morales MS de Á. Ankylosing spondylitis and uveitis: overview. Rev Bras Reumatol. octubre de 2012;52(5):742-56.
  12. Heijde D van der, Ramiro S, Landewé R, Baraliakos X, Bosch FV den, Sepriano A, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 1 de junio de 2017;76(6):978-91.
  13. Banegas Illescas ME, López Menéndez C, Rozas Rodríguez ML, Fernández Quintero RM. Nuevos criterios ASAS para el diagnóstico de espondiloartritis. Diagnóstico de sacroileítis por resonancia magnética. Radiología. 1 de enero de 2014;56(1):7-15.
  14. Chiowchanwisawakit P, Lambert RGW, Conner-Spady B, Maksymowych WP. Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum. agosto de 2011;63(8):2215-25.
  15. Villaverde-García V, Cobo-Ibáñez T, Candelas-Rodríguez G, Seoane-Mato D, Campo-Fontecha PDD, Guerra M, et al. The effect of smoking on clinical and structural damage in patients with axial spondyloarthritis: A systematic literature review. Semin Arthritis Rheum. abril de 2017;46(5):569-83.
  16. Haibel H, Brandt HC, Song IH, Brandt A, Listing J, Rudwaleit M, et al. No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial. Ann Rheum Dis. marzo de 2007;66(3):419-21.
  17. Khanna Sharma S, Kadiyala V, Naidu G, Dhir V. A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitis. Int J Rheum Dis. enero de 2018;21(1):308-14.
  18. Ten Bergen LL, Petrovic A, Krogh Aarebrot A, Appel S. The TNF/IL-23/IL-17 axis-Head-to-head trials comparing different biologics in psoriasis treatment. Scand J Immunol. octubre de 2020;92(4):e12946.

Most read articles by the same author(s)